Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage.

Authors

null

Anthony Ricco

Virginia Commonwealth University Massey Cancer Center, Department of Radiation Oncology, Richmond, VA

Anthony Ricco , Nitai Mukhopadhyay , Diane Holdford , Vicki Skinner , Siddharth Saraiya , Drew Moghanaki , Mitchell Steven Anscher , Michael G. Chang , Xiaoyan Deng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Clinical Trial Registration Number

NCT01117935

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 299)

Abstract #

299

Poster Bd #

L5

Abstract Disclosures

Similar Posters

First Author: Kiyonao Nakamura

First Author: Jacob Samuel Parzen